Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.

Wymenga, A N; van der Graaf, W T; Hofstra, L S; Spijkervet, F K; Timens, W; Timmer-Bosscha, H; Sluiter, W J; van Buuren, A H; Mulder, N H; de Vries, E G

Wymenga, A N; van der Graaf, W T; Hofstra, L S; Spijkervet, F K; Timens, W; Timmer-Bosscha, H; Sluiter, W J; van Buuren, A H; Mulder, N H; de Vries, E G.

Affiliation

Wymenga AN; Department of Internal Medicine, University Hospital Groningen, The Netherlands.

Clin Cancer Res ; 5(6): 1363-8, 1999 Jun.

Article in En | MEDLINE | ID: mdl-10389920

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/complications; Mouthwashes/therapeutic use; Stomatitis/prevention & control; Transforming Growth Factor beta/administration & dosage; Administration, Oral; Adult; Antibodies/blood; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Cell Survival/drug effects; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Mouth Mucosa/drug effects; Mouth Mucosa/pathology; Stomatitis/chemically induced; Stomatitis/complications; Stomatitis/pathology; Transforming Growth Factor beta/blood; Transforming Growth Factor beta/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Stomatitis / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Transforming Growth Factor beta / Mouthwashes Limits: Adult / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Netherlands Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links